Elanix Biotechnologies AG has placed 301,763 shares of the current cash capital increase and is negotiating further financing opportunities

THE INFORMATION CONTAINED IN THIS RELEASE IS NOT TO BE PUBLISHED OR FORWARDED The Management Board of Elanix Biotechnologies AG ("the Company") announces the completion of the capital increase as resolved on July 24, 2018. Totally 301,763 shares were placed at a subscription price of EUR 2 ...